Merck KGaA Acquires JSR Life Sciences Chromatography Business

October 19, 2025

Merck KGaA entered into a definitive agreement and later completed the acquisition of the chromatography business of JSR Life Sciences. The deal adds Amsphere Protein A resins and Protein A chromatography capabilities to Merck’s downstream Process Solutions portfolio, strengthening scalable purification for monoclonal antibodies.

Buyers
Merck KGaA
Targets
JSR Life Sciences' Chromatography Business
Industry
Data & Analytics
Location
Belgium
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.